NasdaqGS - Nasdaq Real Time Price USD

Vor Biopharma Inc. (VOR)

0.2343
+0.0344
+(17.21%)
At close: June 2 at 4:00:00 PM EDT
0.2349
+0.00
+(0.26%)
Pre-Market: 4:44:49 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
122,150
121,185
126,036
93,418
69,018
Operating Income
-122,150
-121,185
-126,036
-93,418
-69,018
Net Non Operating Interest Income Expense
3,554
4,271
8,173
1,324
119
Pretax Income
-118,596
-116,914
-117,863
-92,094
-68,899
Net Income Common Stockholders
-118,596
-116,914
-117,863
-92,094
-70,127
Diluted NI Available to Com Stockholders
-118,596
-116,914
-117,863
-92,094
-70,127
Basic EPS
-1.51
--
-1.75
-2.33
-2.10
Diluted EPS
-1.51
--
-1.75
-2.33
-2.10
Basic Average Shares
82,903.9340
--
67,191.9730
39,551.4200
33,433.2140
Diluted Average Shares
82,903.9340
--
67,191.9730
39,551.4200
33,433.2140
Total Operating Income as Reported
-122,150
-121,185
-126,036
-93,418
-69,018
Total Expenses
122,150
121,185
126,036
93,418
69,018
Net Income from Continuing & Discontinued Operation
-118,596
-116,914
-117,863
-92,094
-68,899
Normalized Income
-118,596
-116,914
-117,863
-92,094
-68,899
Interest Income
3,554
4,271
8,173
1,324
119
Net Interest Income
3,554
4,271
8,173
1,324
119
EBIT
-122,150
-121,185
-126,036
-93,418
-69,018
EBITDA
-118,740
-117,657
-122,544
-90,893
-67,584
Reconciled Depreciation
3,410
3,528
3,492
2,525
1,434
Net Income from Continuing Operation Net Minority Interest
-118,596
-116,914
-117,863
-92,094
-68,899
Normalized EBITDA
-118,740
-117,657
-122,544
-90,893
-67,584
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DSGN Design Therapeutics, Inc.
4.0200
+7.77%
 
CGEM Cullinan Therapeutics, Inc.
8.75
+1.21%
 
ATHA Athira Pharma, Inc.
0.2851
-8.77%
 
PASG Passage Bio, Inc.
0.4362
-0.02%
 
TNFA TNF Pharmaceuticals, Inc.
0.1710
+6.61%
 
GBIO Generation Bio Co.
0.3845
+1.67%
 
MRSN Mersana Therapeutics, Inc.
0.3739
+8.79%
 
BCAB BioAtla, Inc.
0.5100
+24.69%
 
ONCO Onconetix, Inc.
0.0800
+2.56%
 
ABP Abpro Holdings, Inc.
0.2199
+2.90%